Ozempic expiration date?

When Does Ozempic Patent Expiration Happen?

Ozempic, also known as semaglutide, is a medication used to treat type 2 diabetes. The patent for Ozempic was approved in 2017, and it was granted an exclusivity period of five years due to its status as a new chemical entity (NCE).

Why Does Patent Exclusivity Matter?

Patent exclusivity, also known as data exclusivity, provides the patent holder with a temporary monopoly on the market for a certain period. This means that during this time, other companies are not allowed to market the same product in the same country.

How Long Will Ozempic's Patent Remain Exclusive?

The patent for Ozempic expires in [2029] [1] based on the standard 5-year period for NCEs. However, the actual date may vary depending on the country and any potential extensions or modifications to the patent.

Will Biosimilars Enter the Market After Patent Expiration?

Yes, biosimilars, which are similar versions of biologic drugs like Ozempic, can enter the market after the patent expires. Several biosimilars of Ozempic are currently in development [2], and their approval may be contingent upon the expiration of the patent.

References:

[1] https://www.drugpatentwatch.com/drug/semaglutide (accessed: 2023)
[2] https://www.raps.org/news-and-articles/news-articles/2022/2/biosimilar-semaglutide-pipeline-takes-shape (accessed: 2023)

Sources:

1. DrugPatentWatch.com [${1}]
2. Regulatory Focus [${2}]